Literature DB >> 9623520

Hypercalcemia due to parathyroid hormone-related protein secretion by melanoma.

S C Yeung1, O Eton, D W Burton, L J Deftos, R Vassilopoulou-Sellin, R F Gagel.   

Abstract

About 1-2% of melanoma patients develop hypercalcemia. We report hypercalcemia without bone metastasis in a 46-year-old woman with advanced melanoma. The hypercalcemia was associated with elevated serum parathyroid hormone-related protein (PTHrP) levels. An even higher concentration (10 times the serum level) in pleural effusion caused by pleural metastases implied that the source of the increased circulating PTHrP was the melanoma. Immunohistochemical staining of paraffin sections, performed using a monoclonal antibody (9H7) against the peptide sequence 109-141 of human PTHrP, detected PTHrP in the cytoplasm and nucleoli of melanoma cells in an autopsy specimen but not in specimens from this patient prior to onset of hypercalcemia. Considering the evidence, it is very likely that PTHrP production by melanoma caused hypercalcemia in this patient.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9623520     DOI: 10.1159/000023188

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  4 in total

1.  Type I collagen and divalent cation shifts disrupt cell-cell adhesion, increase migration, and decrease PTHrP, IL-6, and IL-8 expression in pancreatic cancer cells.

Authors:  John J Grzesiak; Kathy C Smith; Cheryl Chalberg; Douglas W Burton; Leonard J Deftos; Michael Bouvet
Journal:  Int J Gastrointest Cancer       Date:  2005

2.  Serum calcium, albumin and tumor stage in cutaneous malignant melanoma.

Authors:  Mridul Datta; Paul Savage; James Lovato; Gary G Schwartz
Journal:  Future Oncol       Date:  2016-06-16       Impact factor: 3.404

3.  Parathyroid hormone-related protein and hypercalcemia in patients with metastatic melanoma: case report and review.

Authors:  Peter Attia; Giao Q Phan; Paul H Duray; Steven A Rosenberg
Journal:  Am J Clin Oncol       Date:  2003-02       Impact factor: 2.339

4.  Parathyroid Hormone-Related Peptide-Linked Hypercalcemia in a Melanoma Patient Treated With Ipilimumab: Hormone Source and Clinical and Metabolic Correlates.

Authors:  Teresa Anne Mills; Marlana Orloff; Marina Domingo-Vidal; Paolo Cotzia; Ruth C Birbe; Rossitza Draganova-Tacheva; Maria P Martinez Cantarin; Madalina Tuluc; Ubaldo Martinez-Outschoorn
Journal:  Semin Oncol       Date:  2015-09-08       Impact factor: 4.929

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.